tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

HeraMED Ltd. Faces ASX Suspension Over Reporting Delays

Story Highlights
HeraMED Ltd. Faces ASX Suspension Over Reporting Delays

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

HeraMED Ltd. ( (AU:HMD) ) has shared an announcement.

The securities of HeraMED Ltd., along with those of Antilles Gold Limited and Syntara Limited, have been suspended from quotation on the ASX due to the failure to lodge the required periodic report by the due date. This suspension could impact the company’s market presence and investor confidence, pending the submission of the necessary documentation for reinstatement.

More about HeraMED Ltd.

HeraMED Ltd. operates in the healthcare technology industry, focusing on developing innovative medical devices and solutions aimed at improving patient care and monitoring.

Average Trading Volume: 2,428,505

Technical Sentiment Signal: Sell

Current Market Cap: A$10.51M

For a thorough assessment of HMD stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1